These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 1901446)

  • 1. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989.
    Coleman RW; Rodondi LC; Kaubisch S; Granzella NB; O'Hanley PD
    Am J Med; 1991 Apr; 90(4):439-44. PubMed ID: 1901446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of drug costs within diagnosis related groups.
    Kolar R; Stanaszek W; Osborne J; Dougherty K
    Hosp Pharm; 1984 Nov; 19(11):731-5. PubMed ID: 10310864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoepidemiology of ciprofloxacin: analysis of use patterns and cost impact.
    Marchbanks CR; Graham KK; Barnes J; Dudley MN
    Pharmacotherapy; 1991; 11(1):50-5. PubMed ID: 2020611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community].
    BertrĂ¡n MJ; Trilla A; Codina C; CarnĂ© X; Ribas J; Asenjo MA
    Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):445-51. PubMed ID: 11149168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antibiotic order form guiding rational use of expensive drugs on cost containment.
    Sirinavin S; Suvanakoot P; Sathapatayavongs B; Malatham K
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):636-42. PubMed ID: 10437971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of education and an antibiotic-control program in a tertiary care hospital in Thailand.
    Apisarnthanarak A; Danchaivijitr S; Khawcharoenporn T; Limsrivilai J; Warachan B; Bailey TC; Fraser VJ;
    Clin Infect Dis; 2006 Mar; 42(6):768-75. PubMed ID: 16477551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical redesign using all patient refined diagnosis related groups.
    Sedman AB; Bahl V; Bunting E; Bandy K; Jones S; Nasr SZ; Schulz K; Campbell DA
    Pediatrics; 2004 Oct; 114(4):965-9. PubMed ID: 15466092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic use and cost indicators at a rural hospital: a pilot project.
    Mylotte JM; Weislo P
    Am J Infect Control; 2000 Dec; 28(6):415-20. PubMed ID: 11114611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Xu W; Grabowski J; Douyon R; Thomas J; Henderson W; Charney D
    Health Serv Res; 1998 Dec; 33(5 Pt 1):1237-61. PubMed ID: 9865219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced.
    Meyer E; Buttler J; Schneider C; Strehl E; Schroeren-Boersch B; Gastmeier P; Ruden H; Zentner J; Daschner FD; Schwab F
    J Antimicrob Chemother; 2007 Jun; 59(6):1148-54. PubMed ID: 17434880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic surveillance: the results of a clinical pharmacy intervention program.
    Capers CC; Bess DT; Branam AC; Falbe WJ; Mrochek SA; Haymond JD; Stahl AA
    Hosp Pharm; 1993 Mar; 28(3):206-10, 212. PubMed ID: 10124947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):491-5. PubMed ID: 16583990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, poland--part I.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):485-90. PubMed ID: 16583989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressure ulcers, hospital complications, and disease severity: impact on hospital costs and length of stay.
    Allman RM; Goode PS; Burst N; Bartolucci AA; Thomas DR
    Adv Wound Care; 1999; 12(1):22-30. PubMed ID: 10326353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in antibiotic use, cost and consumption after an antibiotic restriction policy applied by infectious disease specialists.
    Ozkurt Z; Erol S; Kadanali A; Ertek M; Ozden K; Tasyaran MA
    Jpn J Infect Dis; 2005 Dec; 58(6):338-43. PubMed ID: 16377863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Out-patient and home-parenteral antibiotic therapy (OHPAT): evaluation of the impact of one year's experience in Tayside.
    Nathwani D; Morrison J; Seaton RA; France AJ; Davey P; Gray K
    Health Bull (Edinb); 1999 Sep; 57(5):332-7. PubMed ID: 12811880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic prescribing pattern in a medical intensive care unit in Qatar.
    Hanssens Y; Ismaeil BB; Kamha AA; Elshafie SS; Adheir FS; Saleh TM; Deleu D
    Saudi Med J; 2005 Aug; 26(8):1269-76. PubMed ID: 16127527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
    Lu S; Hill J; Fillit H
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of Gram-negative resistance.
    Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
    Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.